Observational studyThe oncologist2019

Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE.

Silvana Leo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.